Skip to main content
OpenTrials

Clinical trial condition

Dementia

Explore clinical trials studying Dementia. Study availability and eligibility vary by location and protocol.

2,729 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

Dementia trial results

Completed

A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

NCT00710684

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • GSK Investigational Site Litchfield Park, Arizona, United States
  • GSK Investigational Site Fresno, California, United States
  • GSK Investigational Site Rancho Mirage, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 102 locations
View Trial Details
Completed

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

NCT00843518

Conditions
Aberrant Motor Behavior in Dementia, Aggression, Alzheimer Disease, +19 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Costa Mesa, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamden, Connecticut, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States
View all 17 locations
View Trial Details
Completed

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease

NCT00348309

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • GSK Investigational Site Litchfield Park, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 249 locations
View Trial Details
Completed

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

NCT02197130

Conditions
Basal Ganglia Diseases, Behavior, Behavioral Symptoms, +19 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
View all 57 locations
View Trial Details

Related conditions